Korean Journal of Medical Ethics
The Korean Society for Medical Ethics
Article

의료인-제약산업 관계의 이해상충과 윤리적 원칙

이일학1, 구영모2,*
Ilhak Lee1, Young-Mo Koo2,*
1연세대학교 의과대학 의료법윤리학과
2울산대학교 의과대학 인문사회의학교실
1College of Medicine, Yonsei University
2Department of Medical Humanities and Social Sciences, University of Ulsan College of Medicine
*교신저자: 구영모. 울산대학교 의과대학 인문사회의학교실. 02-3010-4700. ymkoo@amc.seoul.kr

ⓒ Copyright 2011 The Korean Society for Medical Ethics. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Apr 26, 2011; Accepted: Jun 20, 2011

Published Online: Jun 30, 2011

ABSTRACT

This article examines the four principles of biomedical ethics introduced by Beauchamp and Childress for possible use in deliberating ethical issues that arise in the context of physician-pharmaceutical industry interactions (PPII). PPII is regarded as a threat to the ideal physician-patient relationship because it blurs the scientific, objective, and altruistic ideals of professional medical practice. Several guidelines have been proposed to redress the undesirable effects of PPII, but few have provided any ethical justification or mechanism to resolve possible internal conflicts. The principle-based approach is a good starting point because it focuses on practical solutions for decision-making as well as on theoretical justifications. This article shows how the four ethical principles can be specified and applied in three hypothetical cases of PPII, and how two practical rules, the rule of transparency and avoidance, can be assimilated.

Keywords: 의사-제약산업 관계; 윤리이론; 의료윤리
Keywords: ethical principles; physician-pharmaceutical industry interaction; specification ethics; medical ethics